Previous close | 322.30 |
Open | 323.50 |
Bid | 326.00 x 0 |
Ask | 326.60 x 0 |
Day's range | 322.50 - 328.30 |
52-week range | 293.60 - 447.00 |
Volume | |
Avg. volume | 16,194,360 |
Market cap | 534.138B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | N/A |
EPS (TTM) | -190.70 |
Earnings date | 31 July 2024 - 05 Aug 2024 |
Forward dividend & yield | 12.00 (3.72%) |
Ex-dividend date | 27 Sept 2024 |
1y target est | 356.80 |
Sumitomo Chemical Co., Ltd (TSE:4005), one of Japan's leading chemical companies, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new program to develop functional chemicals with synthetic biology and expand upon the companies' existing biomanufacturing partnership.